These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 30479085

  • 1. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 2. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH, Yu M, Jeong S, Lee JH.
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
    Guo Q, Zhu J, Wu Y, Wen H, Xia L, Wu X, Ju X.
    Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
    [Abstract] [Full Text] [Related]

  • 4. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 5. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V, Lubrano A, Pérez-Regadera JF, Torné A, Gil-Moreno A, Tejerizo-Garcia Á, Vergés R, Díaz-Feijoo B, SEGO Spain-GOG Group.
    Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D, Xu XX, Yan DD, Yuan SH, Lou HM.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):357-362. PubMed ID: 31137169
    [Abstract] [Full Text] [Related]

  • 7. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):772-7. PubMed ID: 20888130
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY.
    Radiat Oncol; 2012 Jan 30; 7():13. PubMed ID: 22289572
    [Abstract] [Full Text] [Related]

  • 9. Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis.
    Lee SW, Hong JH, Yu M, Jeong S, Kim SH, Kim YS, Lee SJ, Lee JH.
    Clin Exp Metastasis; 2021 Oct 30; 38(5):467-474. PubMed ID: 34392458
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 11. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I, Nakayama H, Okamoto N, Kitamura T, Inoue T.
    Int J Gynecol Cancer; 2006 Nov 15; 16(3):1094-100. PubMed ID: 16803491
    [Abstract] [Full Text] [Related]

  • 12. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R, Zhang H, Zou L, Qu Y.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 15; 50(2):125-30. PubMed ID: 25877610
    [Abstract] [Full Text] [Related]

  • 13. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D, Wang D, Wang S, Tian Y, Long Z, Ren X.
    Int J Gynecol Cancer; 2017 Nov 15; 27(9):1935-1942. PubMed ID: 28914639
    [Abstract] [Full Text] [Related]

  • 14. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.
    Yoon SM, Shin KH, Kim JY, Seo SS, Park SY, Moon SH, Cho KH.
    Radiat Oncol; 2010 Sep 15; 5():78. PubMed ID: 20840788
    [Abstract] [Full Text] [Related]

  • 15. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ.
    Int J Gynecol Cancer; 2017 Jun 15; 27(5):994-1000. PubMed ID: 28498239
    [Abstract] [Full Text] [Related]

  • 16. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.
    PLoS One; 2015 Jun 15; 10(4):e0122361. PubMed ID: 25860888
    [Abstract] [Full Text] [Related]

  • 17. Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Wang W, Liu X, Hou X, Lian X, Liu Z, Shen J, Sun S, Yan J, Miao Z, Wang D, Meng Q, Fu J, Zhang F, Qiu J, Hu K.
    Gynecol Oncol; 2019 Nov 15; 155(2):224-228. PubMed ID: 31500891
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
    Wan Q, Yan W, Liu Y, Lin Y, Lu Z.
    Cancer Biomark; 2020 Nov 15; 29(3):327-335. PubMed ID: 32716344
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma.
    Zhu C, Zhang W, Wang X, Jiao L, Chen L, Jiang J.
    Medicine (Baltimore); 2021 Aug 20; 100(33):e26960. PubMed ID: 34414964
    [Abstract] [Full Text] [Related]

  • 20. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I, Nakayama H, Kitamura T, Okamoto N, Inoue T.
    Int J Gynecol Cancer; 2005 Aug 20; 15(4):630-8. PubMed ID: 16014117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.